reports
Co-Diagnostics Inc: 1 director
A director at Co-Diagnostics Inc sold 2,000 shares at 10.455USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom†we laid out our gameplan and what we need to see before having confidence that equity markets ar...
AMGN AMGEN INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
ITW ILLINOIS TOOL WORKS INC.
AMN AMN HEALTHCARE SERVICES INC.
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
AAON AAON INC.
XLRN ACCELERON PHARMA INC
WST WEST PHARMACEUTICAL SERVICES INC.
WEC WEC ENERGY GROUP INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
VNET 21VIANET GROUP INC. SPONSORED ADR CLASS A
VIPS VIPSHOP HOLDINGS LTD SPONSORED ADR
TSLA TESLA INC
TMO THERMO FISHER SCIENTIFIC INC.
TDOC TELADOC HEALTH INC.
STMP STAMPS.COM INC.
SGEN SEAGEN INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
RMD RESMED INC.
RGEN REPLIGEN CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
QDEL QUIDEL CORPORATION
POWI POWER INTEGRATIONS INC.
PG PROCTER & GAMBLE COMPANY
NOVA NOVO NORDISK A/S ADS
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
MUSA MURPHY USA INC.
MNST MONSTER BEVERAGE CORPORATION
3KA STRIDE INC.
LMNX LUMINEX CORP
LLY ELI LILLY AND COMPANY
KR KROGER CO.
KMB KIMBERLY-CLARK CORPORATION
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
JD JD.COM INC. SPONSORED ADR CLASS A
INO INOVIO PHARMACEUTICALS INC.
HRL HORMEL FOODS CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GIS GENERAL MILLS INC.
FLO FLOWERS FOODS INC.
EPZM EPIZYME INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
EBS EMERGENT BIOSOLUTIONS INC.
DVA DAVITA INC.
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CLX CLOROX COMPANY
CASY CASEY'S GENERAL STORES INC.
CALM CAL-MAINE FOODS INC.
BIIB BIOGEN INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
ALLT ALLOT LTD
AKAM AKAMAI TECHNOLOGIES INC.
ABC AMERISOURCEBERGEN CORPORATION
SCI SERVICE CORPORATION INTERNATIONAL
APS. APTOSE BIOSCIENCES
BIO BIO-RAD LABORATORIES INC. CLASS A
CCI CROWN CASTLE INTERNATIONAL CORP
ENPH ENPHASE ENERGY INC.
ZNGA ZYNGA INC. CLASS A
TR TOOTSIE ROLL INDUSTRIES INC.
EVBG EVERBRIDGE INC.
WDFC WD-40 COMPANY
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
WMT WALMART INC.
ASML ASML HOLDING N.V.
CODX CO-DIAGNOSTICS
KALA KALA PHARMACEUTICALS INC.
BKI BLACK KNIGHT INC.
ZLAB ZAI LAB LTD. SPONSORED ADR
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
CTXS CITRIX SYSTEMS INC.
RHHBY ROCHE HOLDING AG ADS
RCUS ARCUS BIOSCIENCES
BILI BILIBILI INC. SPONSORED ADR CLASS Z
DOCU DOCUSIGN INC.
ZM ZOOM VIDEO COMMUNICATIONS INC. CLASS A
RAD RITE AID CORPORATION
VAPO VAPOTHERM
CLVT CLARIVATE PLC (A)
BJ BJ'S WHOLESALE CLUB HOLDINGS
VIR VIR BIOTECHNOLOGY
GSX GSX TECHEDU INC. SPONSORED ADR CLASS A
Co-Diagnostics and CoSara to Launch IVD Products to India Market
Co-Diagnostics and CoSara to Launch IVD Products to India Market CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus recently granted regulatory approval by CDSCO to formally launch at India Diagnostic Expo Salt Lake City, Jan. 01, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming India Diagnostic Expo with its Indian joint venture, CoSara Diag...
Co-Diagnostics, Inc. Continues to Execute on International Expansion
Co-Diagnostics, Inc. Continues to Execute on International Expansion Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana Salt Lake City, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in a recent visit to Ghana the Company collaborated with Dare Labs to set up the largest private molecular diagnostics laboratory in Kum...
Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products
Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products Vector Smart™ ZDC multiplex PCR test to aid prevention of tropical disease proliferation in the US and abroad Salt Lake City, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the product launch of their Vector Smart™ ZDC test, used to identify the presence of Zika, dengue, and chikungunya in mosquito populations, in response to demand from domestic and foreign marke...
Co-Diagnostics to Present Technology Applications at 4th ACTC Liquid B...
Co-Diagnostics to Present Technology Applications at 4th ACTC Liquid Biopsy Conference in Corfu, Greece Salt Lake City, UT, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting liquid biopsy applications of its patented CoPrimer™ technology at the 4th Advances in Circulating Tumor Cells (ACTC) conference, “Liquid Biopsy: Latest Advances and Future Challenges,” held October 2-5 2019 in Corfu, Greece. Liquid biopsy ...
Co-Diagnostics, Inc. to Launch Vector Control Products into Midwest US...
Co-Diagnostics, Inc. to Launch Vector Control Products into Midwest US at OPMA Conference Company will host booth to introduce and promote mosquito abatement products to midwestern states in Tulsa, OK on Sept 19-20 Salt Lake City, UT, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and launching its vector control testing products to the midwestern USA at the Oklahoma Pest Management Association (OPMA)...
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Ag...
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology Expansion to include increased royalties and cover additional applications for Company’s technology platform Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies (“LGC”), a global leader in the design, development, and manufacture of sophisticated, custom oligonu...
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global...
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019 Salt Lake City, Utah, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be featured as a presenting company at the 21st Annual Rodman and Renshaw Global Investment Conference on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City. The conference is sponsored by H.C. Wainwright & Co., LLC, who init...
Co-Diagnostics, Inc. to Host 2nd Semiannual Distributor Conference on ...
Co-Diagnostics, Inc. to Host 2nd Semiannual Distributor Conference on Sept 10-12 Event to include demos and training for distributors and end-users of Company’s products Salt Lake City, Utah, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host the 2nd Semiannual Co-Diagnostics Distributor Conference on September 10-12, 2019 at the Company’s headquarters in Salt Lake City, Utah. Conference attendees consist of current ...
Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 201...
Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 2019 Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its operating results on SEC Form 10-Q for the 3 month period ending June 30, 2019, a copy of which will be available on the Company’s website. Managemen...
Co-Diagnostics, Inc. to Present Products and Services at the 2019 AACC...
Co-Diagnostics, Inc. to Present Products and Services at the 2019 AACC Expo August 4-8 Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation Salt Lake City, Utah, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting at the 71st annual AACC Scientific Meeting and Clinical Lab Expo in Anaheim, California on August 4-8, 2019 and pursuing ...
Co-Diagnostics, Inc. Vector Control Products Continue to Gain Acceptan...
Co-Diagnostics, Inc. Vector Control Products Continue to Gain Acceptance Across the US Salt Lake City, UT, July 30, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the growing use of the Company’s Vector Smart™ NAM-W test by mosquito abatement districts to identify the presence of West Nile virus (WNV). Press coverage from July 27 mosquito abatement districts already using the Company’s NAM-W test in their pursuit of improving public health, a...
Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Can...
Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Salt Lake City, UT, July 18, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today favorable results of a study to detect cancer mutations using its patented CoPrimer™ technology, with applications in liquid biopsy and companion diagnostic tests. Unlike invasive and more expensive tissue biopsies, liquid biopsies identify traces of cancer in a...
Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Produ...
Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Product Salt Lake City, UT, July 11, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Product Salt Lake City, Utah – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the product launch of their Vector Smart™ NAM test, used to identify the presence of West Nile virus, St. Louis encephalitis, and western equine encephalitis in mosquito populations. Diseases like Wes...
Co-Diagnostics CEO to Discuss Strategic Direction in a Lytham Partners...
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (Nasdaq: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostic testing, announced today that it will discuss the Company’s strategic direction and recent corporate developments on Thursday, April 19, 2018 at 2:00 pm ET (1:00 pm CT) in a Lytham Partners’ Virtual Presentation and Fireside Chat. The presentation will be available online with interested parties able to participate by following the webcast links below at the time o...
Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Co...
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced the filing of its initial Annual Report on Form 10-K as a public company. Co-Diagnostics completed its initial public offering (“IPO”) on July 17, 2017. 2017 Financial Results: Revenue for the year totaled $7,700, primarily licensing revenue, compared to zero revenue in full year 2016. Deferred inc...
Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing...
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today an update on the Joint Venture (“JV”) manufacturing facility in Vadodara, India. CoSara Diagnostics, Pvt., Ltd. (“CoSara”), the JV for manufacturing with Synbiotics Limited, a group company of Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets, broke ground on the future Good...
Co-Diagnostics Inc Announces Positive Results from Co-Primersâ„¢ Techn...
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that ongoing research and development activities of the Company’s Co-Primer™ platform technology has yielded positive results in demonstrating the capabilities of Co-Primers in multiplex tests for SNP detection. The Company will utilize its proprietary design software and patent-pending Co-Primer t...
Co-Diagnostics, Inc. Ships Product to India for Validation Study
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today a product shipment to India containing tests to be sold as Research Use Only as well as others to be used in validation studies in that country. The validation study for the most recent iteration of the Company’s test for tuberculosis will be conducted at the All India Institute of Medical Sciences (“AIIMS”). With nearly 20% of ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.